| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MEDP | Common Stock | Purchase | $8,347,248 | +56,557 | +1% | $147.59 | 5,660,986 | 06 Sep 2022 | Direct | F1, F2 |
| transaction | MEDP | Common Stock | Purchase | $8,524,271 | +56,557 | +1% | $150.72 | 5,717,543 | 07 Sep 2022 | Direct | F1, F3 |
| Id | Content |
|---|---|
| F1 | The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 17, 2022, as amended on May 3, 2022 and August 15, 2022. |
| F2 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $144.76 to $149.51. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |
| F3 | The reported price is a weighted average price. These shares were purchased in multiple transactions ranging from $145.30 to $154.52. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request. |